Connect your AI

Acadia Pharmaceuticals ACAD Price / sales

Price / sales at other companies

BiogenBIIB

2.7×+0.7×

Neurocrine BiosciencesNBIX

4.3×-0.3×

Catalyst PharmaceuticalCPRX

5.1×-0.4×

PTC TherapeuticsPTCT

6.8×+4.6×

BridgeBio PharmaBBIO

24.8×-26.8×

TG TherapeuticsTGTX

7.6×-8.5×

Other financials

Income statement

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

Profitability

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

market cap/total revenue=3.5×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Acadia Pharmaceuticals's price / sales?: Acadia Pharmaceuticals (ACAD) reported price / sales of 3.5× in Q1 2026.
How has Acadia Pharmaceuticals's price / sales changed year-over-year?: Acadia Pharmaceuticals's price / sales increased by 24.6% year-over-year, from 2.8× to 3.5×.
What is the long-term trend for Acadia Pharmaceuticals's price / sales?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's price / sales has grown at a -26.3% compound annual growth rate (CAGR), from 19.5× to 4.2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.